EPCAM and breast carcinoma: Further we assessed DMFS for breast cancer patients (M0 and M0mts, n = 48) with CD45-EpCAM-CK7/8-CD24+N-cadherin- CCs count below and above established cut-off (218.3 cells/1 ml).